Alembic Pharmaceuticals received USFDA approval for its Sumatriptan injection, a generic equivalent for treating migraines and cluster headaches. This marks Alembic's first drug device combination.
Alembic Pharma receives US FDA final approval for sumatriptan injection USP, 4 mg/0.5 mL and 6 mg/0.5 mL, single-dose autoinjector system: Our Bureau, Mumbai Monday, November 10, ...
Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration ...
Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...
MUMBAI, Feb 17 (Reuters) - Drug firm Wockhardt Ltd on Tuesday said it will be launching Sumatriptan injections in the U.S. following following final approval from the U.S. Food & Drug Administration.
Ltd on Monday said it has received final approval from the US health regulator for its generic version of Sumatriptan injection used in treatment of migraine. The approval by the US Food & Drug ...
Capital Market on MSN
Alembic receives USFDA approval for its first drug device combination product
Alembic Pharmaceuticalshas received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback